DIGESTIVE CANCER
Clinical trials for DIGESTIVE CANCER explained in plain language.
Never miss a new study
Get alerted when new DIGESTIVE CANCER trials appear
Sign up with your email to follow new studies for DIGESTIVE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in fight against Tough-to-Treat bile duct cancer
Disease control CompletedThis study tested a combination of two treatments—a drug called regorafenib and a modified chemotherapy regimen (mGEMOX)—for people with advanced bile duct cancer that could not be cured by surgery. The main goals were to find a safe dose of the drug combination and to see how we…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for Tough-to-Treat stomach and digestive cancers
Disease control CompletedThis study tested an experimental drug called RC108 in patients with advanced cancers of the digestive system, such as stomach, colon, liver, or pancreatic cancer, whose tumors had a specific marker called c-Met. The main goals were to see if the drug could shrink tumors, how saf…
Matched conditions: DIGESTIVE CANCER
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Patients' smartphone reports could cut wasted cancer drugs
Disease control CompletedThis study tested whether asking patients to report their symptoms via a smartphone or computer before a chemotherapy appointment could help doctors decide whether to prepare their treatment drugs. The goal was to see if this patient feedback was as useful as a doctor's exam in m…
Matched conditions: DIGESTIVE CANCER
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC